Search research articles
Contact Us
Filters
Showing results (1-10 of 50) with videos related to
Page
of 5
Sort By:
Acta Neurologica Scandinavica
|
October 26, 2017
Trials of antivirals in the treatment of multiple sclerosis
J Lycke
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 5, 2011
High nationwide prevalence of multiple sclerosis in Sweden
C Ahlgren, A Odén, J Lycke
Journal of Neurology
|
May 16, 2002
Asymptomatic visual loss in multiple sclerosis
J Lycke, P O Tollesson, L Frisén
Journal of the Neurological Sciences
|
November 1, 1995
Glial fibrillary acidic protein in CSF of multiple sclerosis patients: relation to neurological deficit
L E Rosengren, J Lycke, O Andersen
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 31, 2010
High risk of MS in Iranian immigrants in Gothenburg, Sweden
C Ahlgren, J Lycke, A Odén, et al.
Journal of Biomechanical Engineering
|
March 16, 2019
Computational Modeling of Developing Cartilage Using Experimentally Derived Geometries and Compressive Moduli
Roy J Lycke, Michael K Walls, Sarah Calve
Acta Neurologica Scandinavica
|
September 1, 1990
Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden
A Svenningsson, B Runmarker, J Lycke, et al.
Journal of the Neurological Sciences
|
April 25, 2015
Rituximab treatment did not aggravate ongoing progressive multifocal leukoencephalopathy in a patient with multiple sclerosis
F Asztely, E Gilland, M P Wattjes, et al.
Journal of Neuroimmunology
|
April 22, 2006
IL-6 and CCL2 levels in CSF are associated with the clinical course of MS: implications for their possible immunopathogenic roles
C Malmeström, B A Andersson, S Haghighi, et al.
The Journal of Antimicrobial Chemotherapy
|
December 1, 1989
Acyclovir concentrations in serum and cerebrospinal fluid at steady state
J Lycke, O Andersen, B Svennerholm, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 50) with videos related to
Sort By:
Page
of 5
Acta Neurologica Scandinavica
|
October 26, 2017
Trials of antivirals in the treatment of multiple sclerosis
J Lycke
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 5, 2011
High nationwide prevalence of multiple sclerosis in Sweden
C Ahlgren, A Odén, J Lycke
Journal of Neurology
|
May 16, 2002
Asymptomatic visual loss in multiple sclerosis
J Lycke, P O Tollesson, L Frisén
Journal of the Neurological Sciences
|
November 1, 1995
Glial fibrillary acidic protein in CSF of multiple sclerosis patients: relation to neurological deficit
L E Rosengren, J Lycke, O Andersen
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 31, 2010
High risk of MS in Iranian immigrants in Gothenburg, Sweden
C Ahlgren, J Lycke, A Odén, et al.
Journal of Biomechanical Engineering
|
March 16, 2019
Computational Modeling of Developing Cartilage Using Experimentally Derived Geometries and Compressive Moduli
Roy J Lycke, Michael K Walls, Sarah Calve
Acta Neurologica Scandinavica
|
September 1, 1990
Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden
A Svenningsson, B Runmarker, J Lycke, et al.
Journal of the Neurological Sciences
|
April 25, 2015
Rituximab treatment did not aggravate ongoing progressive multifocal leukoencephalopathy in a patient with multiple sclerosis
F Asztely, E Gilland, M P Wattjes, et al.
Journal of Neuroimmunology
|
April 22, 2006
IL-6 and CCL2 levels in CSF are associated with the clinical course of MS: implications for their possible immunopathogenic roles
C Malmeström, B A Andersson, S Haghighi, et al.
The Journal of Antimicrobial Chemotherapy
|
December 1, 1989
Acyclovir concentrations in serum and cerebrospinal fluid at steady state
J Lycke, O Andersen, B Svennerholm, et al.
Page
of 5